Related references
Note: Only part of the references are listed.Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
Youngwook Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers
Min S. Kim et al.
APMIS (2013)
Oncogenic ERBB3 Mutations in Human Cancers
Bijay S. Jaiswal et al.
CANCER CELL (2013)
Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome
Erin M. George et al.
GYNECOLOGIC ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Mark Sausen et al.
NATURE GENETICS (2013)
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Silvia Bea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Renal Cell Neoplasms Contain Shared Tumor Type-Specific Copy Number Variations
John M. Krill-Burger et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
E. Seront et al.
ANNALS OF ONCOLOGY (2012)
Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
John Moroney et al.
CLINICAL CANCER RESEARCH (2012)
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
Chris T. Williamson et al.
EMBO MOLECULAR MEDICINE (2012)
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer
Siqing Fu et al.
GYNECOLOGIC ONCOLOGY (2012)
Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types
Sian Jones et al.
HUMAN MUTATION (2012)
Low-grade serous carcinomas of the ovary contain very few point mutations
Sian Jones et al.
JOURNAL OF PATHOLOGY (2012)
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Elisabetta Kuhn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Noncanonical Mismatch Repair as a Source of Genomic Instability in Human Cells
Javier Pena-Diaz et al.
MOLECULAR CELL (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
Matthieu Le Gallo et al.
NATURE GENETICS (2012)
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
Akihiro Fujimoto et al.
NATURE GENETICS (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature
Berna Bozkurt Duman et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2011)
Uterine Carcinosarcoma
Sherif A. El-Nashar et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2011)
Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin
Whitfield B. Growdon et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component
Renske A. de Jong et al.
MODERN PATHOLOGY (2011)
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
Maria C. Villarroel et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Primary mixed mullerian tumor of the vagina-A case report with review of the literature
Arvind Ahuja et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Uterine Carcinosarcomas (Malignant Mixed Mullerian Tumours): A Review with Special Emphasis on the Controversies in Management
Rani Kanthan et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Malignant mixed mullerian tumor of the fallopian tube: report of two cases and review of literature
Yang-Mei Shen et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
A Phase 2 Study of the Oral Mammalian Target of Rapamycin Inhibitor, Everolimus, in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
CANCER (2010)
Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing
Khairul I. Ansari et al.
FEBS JOURNAL (2010)
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan et al.
NATURE (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hijacking the Chromatin Remodeling Machinery: Impact of SWI/SNF Perturbations in Cancer
Bernard Weissman et al.
CANCER RESEARCH (2009)
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder
Andrew B. Armstrong et al.
MODERN PATHOLOGY (2009)
The chromatin remodeller ACF acts as a dimeric motor to space nucleosomes
Lisa R. Racki et al.
NATURE (2009)
A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4
Jeongkyung Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
RhoA-Dependent regulation of cell migration by the tumor suppressor hSNF5/INI1
Julie Caramel et al.
CANCER RESEARCH (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer
Stacey A. South et al.
OBSTETRICS AND GYNECOLOGY (2007)
BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase
JE Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes
J Sierra et al.
GENES & DEVELOPMENT (2006)
Malignant mixed mullerian tumor (MMMT) of the cervix
NK Sharma et al.
GYNECOLOGIC ONCOLOGY (2005)
Malignant mixed Mullerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome
M Callister et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer
RE Curtis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Two related ARID family proteins are alternative subunits of human SWI/SNF complexes
XM Wang et al.
BIOCHEMICAL JOURNAL (2004)
Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: A genetic study with special reference to histogenesis
Z Jin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2003)
Mutational analysis of the PTEN gene in human uterine sarcomas
JM Lancaster et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Share Paper
